Ritonavir & Foetal exposure during pregnancy

14.3%

of users reported Foetal exposure during pregnancy

60.0%

also reported Severe reaction

54.8%

are men

Severe reaction

60.0%

Birth Defects

24.0%

Hospitalization

8.0%

Death

4.0%

Life-threatening condition

2.0%

Disability

2.0%

Ritonavir: general information

30 - 39 years

22.1%

40 - 49 years

35.8%

50 - 59 years

36.3%

60 - 69 years

<0.1%

70 - 79 years

5.8%